US Patent 7507580 Ztnfr14, a tumor necrosis factor receptor

Patent 7507580 was granted and assigned to ZymoGenetics on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

ZymoGenetics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75075800

Date of Patent

March 24, 2009

Patent Application Number

109675270

Date Filed

October 18, 2004

Patent Primary Examiner

‌

Lorraine Spector

Patent abstract

Novel tumor necrosis factor receptor (TNFR) polypeptides, polynucleotides encoding the polypeptides, antibodies and related compositions and methods are disclosed. The polypeptides may be used for detecting ligand, as well as agonists and antagonists. The polypeptides, polynucleotides and antibodies may also be used in methods that modulate tumor growth, metastasis, and immunity such as separating resting from stimulated immune cells.